samples/APOLLO-2_description.txt

The Applied Proteogenomics Organizational Learning and Outcomes
(APOLLO) network is a collaboration between NCI, the Department of
Defense (DoD), and the Department of Veterans Affairs (VA) to
incorporate proteogenomics into patient care as a way of looking
beyond the genome, to the activity and expression of the proteins that
the genome encodes. The emerging field of proteogenomics aims to
better predict how patients will respond to therapy by screening their
tumors for both genetic abnormalities and protein information, an
approach that has been made possible in recent years due to advances
in proteomic technology.

The APOLLO network collects data that include a full set of medical
images, including CT and MRI scans, obtained before and during
treatment. Each set of images can be connected to the patient’s
genomic, proteomic, and clinical data. The real data will be made
available publicly through the Genomic Data Commons, Proteomics Data
Commons, and Cancer Imaging Archive. By using all available data,
researchers will be able to study the relationships among these data,
validate results, and develop predictive and prognostic models to
improve patient care. Aligning this data with the NCI Cancer Research
Data Commons is currently a time intensive manual effort.